Bellevue Life Sciences Stock Price on November 28, 2024
| BLAC Stock | 11.17 0.09 0.80% |
If you're considering investing in Bellevue Stock, it is important to understand the factors that can impact its price. As of today, the current price of Bellevue Life stands at 11.17, as last reported on the 30th of November, with the highest price reaching 11.30 and the lowest price hitting 11.17 during the day. At this point, Bellevue Life is not too volatile. Bellevue Life Sciences secures Sharpe Ratio (or Efficiency) of 0.0378, which signifies that the company had a 0.0378% return per unit of risk over the last 3 months. We have found thirty technical indicators for Bellevue Life Sciences, which you can use to evaluate the volatility of the firm. Please confirm Bellevue Life's Mean Deviation of 0.5041, downside deviation of 1.93, and Risk Adjusted Performance of 0.0344 to double-check if the risk estimate we provide is consistent with the expected return of 0.0627%.
At present, Bellevue Life's Common Stock Shares Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 38.5 M, whereas Other Stockholder Equity is forecasted to decline to 205.20. . The current year's Price Earnings Ratio is expected to grow to 153.53, whereas Price Book Value Ratio is forecasted to decline to 1.72. Bellevue Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Bellevue |
Sharpe Ratio = 0.0378
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | BLAC | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.66 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Bellevue Life is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bellevue Life by adding it to a well-diversified portfolio.
Price Book 3.051 | Book Value (0.69) | Enterprise Value 47.3 M | Enterprise Value Ebitda (98.70) | Shares Float 1.8 M |
Related Headline
Visa Headline on 27th of November 2024
RPg Family Wealth Advisory LLC Raises Stock Holdings in Visa... by thelincolnianonline.com
RPg Family Wealth Advisory LLC boosted its position in shares of Visa Inc. by 3.1 percent in the third quarter, according to its most recent filing with the Securities Exchange Commission. The fund owned 28,809 shares of the credit-card processors stock after buying an additional 876 shares during the quarter. Visa
Bellevue Life Valuation on November 28, 2024
It is possible to determine the worth of Bellevue Life on a given historical date. On November 28, 2024 Bellevue was worth 11.26 at the beginning of the trading date compared to the closed value of 11.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bellevue Life stock. Still, in general, we apply an absolute valuation method to find Bellevue Life's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bellevue Life where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bellevue Life's related companies.
| Open | High | Low | Close | Volume | |
| 11.26 | 11.26 | 11.26 | 11.26 | 969.00 | |
11/27/2024 | 11.26 | 11.26 | 11.26 | 11.26 | 1.00 |
| 11.30 | 11.30 | 11.17 | 11.17 | 1,607 |
| Backtest Bellevue Life | | | Bellevue Life History | | | Bellevue Life Valuation | Previous | Next |
Bellevue Life Trading Date Momentum on November 28, 2024
| On November 29 2024 Bellevue Life Sciences was traded for 11.17 at the closing time. The top price for the day was 11.30 and the lowest listed price was 11.17 . The trading volume for the day was 1.6 K. The trading history from November 29, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.80% . The overall trading delta against the current closing price is 0.36% . |
Bellevue Life Sciences Fundamentals Correlations and Trends
By evaluating Bellevue Life's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bellevue Life's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bellevue financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bellevue Life Stock history
Bellevue Life investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bellevue is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bellevue Life Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bellevue Life stock prices may prove useful in developing a viable investing in Bellevue Life
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5.6 M | 6.1 M | |
| Net Loss | -3.8 K | -4 K |
Bellevue Life Stock Technical Analysis
Bellevue Life technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bellevue Life Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Bellevue Life Sciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bellevue Life November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Bellevue Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bellevue Life shares will generate the highest return on investment. By undertsting and applying Bellevue Life stock market strength indicators, traders can identify Bellevue Life Sciences entry and exit signals to maximize returns
Bellevue Life Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bellevue Life's price direction in advance. Along with the technical and fundamental analysis of Bellevue Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bellevue to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0344 | |||
| Jensen Alpha | 0.0722 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | (0.33) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Bellevue Stock analysis
When running Bellevue Life's price analysis, check to measure Bellevue Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellevue Life is operating at the current time. Most of Bellevue Life's value examination focuses on studying past and present price action to predict the probability of Bellevue Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bellevue Life's price. Additionally, you may evaluate how the addition of Bellevue Life to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |